Bleakley Financial Group LLC Buys New Position in Encompass Health Corporation $EHC

Bleakley Financial Group LLC purchased a new position in Encompass Health Corporation (NYSE:EHC) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 10,653 shares of the company’s stock, valued at approximately $1,306,000.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. WPG Advisers LLC purchased a new position in Encompass Health in the first quarter worth $27,000. Mitsubishi UFJ Asset Management Co. Ltd. increased its position in shares of Encompass Health by 749.0% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 416 shares of the company’s stock valued at $42,000 after purchasing an additional 367 shares during the last quarter. Arlington Trust Co LLC raised its holdings in shares of Encompass Health by 22.9% during the 1st quarter. Arlington Trust Co LLC now owns 671 shares of the company’s stock valued at $68,000 after buying an additional 125 shares in the last quarter. Park Place Capital Corp bought a new stake in Encompass Health in the 2nd quarter worth approximately $72,000. Finally, Caitong International Asset Management Co. Ltd boosted its stake in Encompass Health by 19.0% in the first quarter. Caitong International Asset Management Co. Ltd now owns 720 shares of the company’s stock worth $73,000 after buying an additional 115 shares in the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on EHC shares. Zacks Research upgraded shares of Encompass Health from a “hold” rating to a “strong-buy” rating in a report on Tuesday, October 21st. Truist Financial upped their price target on shares of Encompass Health from $135.00 to $140.00 and gave the company a “buy” rating in a research report on Thursday, August 14th. UBS Group lifted their price objective on Encompass Health from $140.00 to $150.00 and gave the stock a “buy” rating in a report on Thursday, October 2nd. Bank of America boosted their target price on Encompass Health from $145.00 to $160.00 and gave the company a “buy” rating in a research note on Wednesday, September 10th. Finally, KeyCorp raised their price target on Encompass Health from $135.00 to $140.00 and gave the stock an “overweight” rating in a research report on Tuesday, September 16th. Two equities research analysts have rated the stock with a Strong Buy rating and eight have assigned a Buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $139.86.

Insiders Place Their Bets

In other Encompass Health news, EVP Patrick William Tuer sold 1,020 shares of the company’s stock in a transaction that occurred on Wednesday, August 27th. The stock was sold at an average price of $123.59, for a total transaction of $126,061.80. Following the transaction, the executive vice president owned 18,846 shares in the company, valued at approximately $2,329,177.14. This represents a 5.13% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 2.00% of the company’s stock.

Encompass Health Stock Performance

Encompass Health stock opened at $126.23 on Friday. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.76. The firm has a market cap of $12.71 billion, a P/E ratio of 24.70, a P/E/G ratio of 2.21 and a beta of 0.93. Encompass Health Corporation has a 1-year low of $87.85 and a 1-year high of $127.99. The firm has a 50-day moving average of $124.23 and a 200-day moving average of $118.20.

Encompass Health (NYSE:EHC) last released its quarterly earnings results on Wednesday, March 16th. The company reported $0.93 EPS for the quarter. The business had revenue of $136.30 million during the quarter. Encompass Health had a return on equity of 17.83% and a net margin of 9.22%. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. Sell-side analysts expect that Encompass Health Corporation will post 4.8 EPS for the current year.

Encompass Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be issued a $0.19 dividend. The ex-dividend date is Friday, January 2nd. This represents a $0.76 annualized dividend and a yield of 0.6%. Encompass Health’s dividend payout ratio (DPR) is 14.87%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.